[A11-30] Apixaban - Benefit assessment according to § 35a Social Code Book V (dossier assessment)
Last updated 15.03.2012
Project no.:
A11-30
Commission:
Commission awarded on 14.12.2011 by the Federal Joint Committee (G-BA).
Report type:
Dossier assessment
Status:
Commission completed
Department/Division:
Drug Assessment
Topic:
Heart and circulation
Note:
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
| Project no. | Title | Status |
|---|---|---|
| A14-28 | Apixaban (extension of approval) - Benefit assessment according to §35a Social Code Book V (dossier assessment) | Commission completed |
| A12-20 | Apixaban - Benefit assessment according to § 35a Social Code Book V (dossier assessment) | Commission completed |
| A11-11 | Apixaban - Consultation on content and completeness of the dossier | Commission completed |
Federal Joint Committee (G-BA)
2012-06-07 A G-BA decision was published.